Literature DB >> 14044286

MULTIPLE ANTIBODY PRODUCTION IN MYASTHENIA GRAVIS.

H VAN DER GELD, T E FELTKAMP, J VAN LOGHEM, H J OOSTERHUIS, A BIEMOND.   

Abstract

Keywords:  ANTIBODY FORMATION; ANTIGEN-ANTIBODY REACTIONS; AUTOIMMUNE DISEASES; FLUORESCENT ANTIBODY TECHNIC; HEMAGGLUTINATION INHIBITION TESTS; MYASTHENIA GRAVIS

Mesh：

Year:  1963        PMID： 14044286     DOI： 10.1016/s0140-6736(63)93055-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  27 in total

1.  Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.

Authors:  W M Behan; P O Behan; J A Simpson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-11       Impact factor: 10.154

2.  MYASTHENIA GRAVIS WITH HYPERGAMMAGLOBULINAEMIA AND ANTIBODIES.

Authors:  H J OOSTERHUIS; H VAN DER GELD; T E FELTKAMP; F PEETOOM
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-08       Impact factor: 10.154

3.  NEONATAL MYASTHENIA GRAVIS.

Authors:  G M STERN; J M HALL; D C ROBINSON
Journal:  Br Med J       Date:  1964-08-01

4.  CASE OF HASHIMOTO'S DISEASE WITH MYASTHENIA GRAVIS.

Authors:  J J DALY; E JACKSON
Journal:  Br Med J       Date:  1964-03-21

5.  IMMUNOLOGICAL DISTURBANCES IN MYASTHENIA GRAVIS WITH A REPORT OF HASHIMOTO'S DISEASE DEVELOPING AFTER THYMECTOMY.

Authors:  J A SIMPSON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1964-12       Impact factor: 10.154

6.  AUTOIMMUNITY IN MYASTHENIA GRAVIS.

Authors:  M THIERY
Journal:  Br Med J       Date:  1965-04-03

7.  AUTO-ANTIBODY STUDIES IN INTERSTITIAL PULMONARY FIBROSIS.

Authors:  M TURNER-WARWICK; D DONIACH
Journal:  Br Med J       Date:  1965-04-03

8.  Thymic function and disease processes.

Authors: 
Journal:  Br Med J       Date:  1967-08-19

Review 9.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

10.  MYASTHENIA GRAVIS: MEDICAL ASPECTS.

Authors:  L R ZELDOWICZ; W S BUCKLER
Journal:  Can Med Assoc J       Date:  1965-07-31       Impact factor: 8.262
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.